Register
Register
Register

Project cooperationUpdated on 7 May 2026

AI‑Driven Hantavirus Outbreak Simulation & Biosafety Decision‑Support for the MV Hondius

representador legal at TORMENTA‑IA3, SL

Madrid, Spain

About

Project Overview This platform is an AI‑driven Hantavirus outbreak scenario simulator designed to support operational decision‑making, biosafety oversight, and crisis‑management preparedness aboard maritime vessels such as the MV Hondius and other remote‑environment infrastructures. The system does not perform medical diagnosis. Instead, it provides computational modelling, environmental reasoning, and multi‑AI consensus analysis to help operators anticipate risks and coordinate responses during high‑uncertainty events.

Core Capabilities

  • Simulation of Hantavirus transmission scenarios aboard vessels and confined environments

  • AI‑based reasoning for containment strategies, crew/passenger flow, and resource allocation

  • Integration of telemetry, navigation data, environmental variables, and human‑mobility patterns

  • Digital Twin of the MV Hondius (or any vessel) to test operational responses in real time

  • Multi‑AI consensus engine for high‑uncertainty decision‑support

  • Fully aligned with the EU AI Act, operating strictly as a decision‑support simulator, not a medical device

Applications

  • Maritime operations (expedition vessels, cruise ships, polar routes)

  • Remote scientific stations and isolated infrastructures

  • Civil protection and emergency coordination

  • Crisis‑response training and preparedness

  • Biosafety planning for confined environments

Looking For

  • Partners for operational pilots on vessels or remote infrastructures

  • Collaboration on sensor integration, maritime telemetry, and early‑warning systems

  • Expertise in AI ethics, governance, and safety frameworks

  • Participation in Horizon Europe consortia (Clusters: Civil Security, Digital, Space, Climate Adaptation)

Topic

  • HORIZON-MISS-2026-02-CANCER-01: Virtual Human Twin (VHT) Models for Cancer Research
  • HORIZON-MISS-2026-02-CANCER-02: Microbiome for early cancer prediction before the onset of disease
  • HORIZON-MISS-2026-02-CANCER-03: Pragmatic clinical trials to optimise immunotherapeutic interventions for patients with refractory cancers
  • HORIZON-MISS-2026-02-CANCER-04: Earlier and more precise palliative care
  • HORIZON-MISS-2026-02-CANCER-05: Boosting mental health of young cancer survivors through the European Cancer Patient Digital Centre (ECPDC)
  • HORIZON-MISS-2026-02-CANCER-06: Development of a research capacity building programme on cancer with and for Ukraine
  • HORIZON-MISS-2026-02-CANCER-07: Improve the Quality of Life of older cancer patients
  • HORIZON-MISS-2026-03-OCEAN-01: Large-scale demonstration for mapping the distribution and condition of marine habitats to implement the Nature Restoration Regulation
  • HORIZON-MISS-2026-03-OCEAN-02: Addressing aquatic pollution and biodiversity loss through nature positive solutions in the land-sea connection
  • HORIZON-MISS-2026-03-OCEAN-03: By fishers, for fishers: co-management of marine and freshwaters ecosystems and resources
  • HORIZON-MISS-2026-03-OCEAN-04: Towards a European network of ocean technology testing sites
  • HORIZON-MISS-2026-03-OCEAN-05: Regional (sea-basins) components of the EU Digital Twin Ocean

Type

  • Consortium/Coordinator seeks Partners
  • Offering Expertise to Consortias

Organisation

TORMENTA‑IA3, SL

Company (SME)

Madrid, Spain

Similar opportunities

  • Project cooperation

    AI‑Driven Hantavirus Biosafety & Operational Risk Simulator for Extreme Environments

    • Offering Expertise to Consortias
    • Consortium/Coordinator seeks Partners
    • HORIZON-MISS-2026-02-CANCER-04: Earlier and more precise palliative care
    • HORIZON-MISS-2026-02-CANCER-01: Virtual Human Twin (VHT) Models for Cancer Research
    • HORIZON-MISS-2026-02-CANCER-07: Improve the Quality of Life of older cancer patients
    • HORIZON-MISS-2026-02-CANCER-02: Microbiome for early cancer prediction before the onset of disease
    • HORIZON-MISS-2026-02-CANCER-06: Development of a research capacity building programme on cancer with and for Ukraine
    • HORIZON-MISS-2026-02-CANCER-03: Pragmatic clinical trials to optimise immunotherapeutic interventions for patients with refractory cancers
    • HORIZON-MISS-2026-02-CANCER-05: Boosting mental health of young cancer survivors through the European Cancer Patient Digital Centre (ECPDC)

    Dani Ortiz

    representador legal at TORMENTA‑IA3, SL

    Madrid, Spain

  • Project cooperation

    MaternAI LiveCare™ – Continuous Lifestyle and Maternal Health Intelligence

    • HORIZON-MISS-2026-02-CANCER-04: Earlier and more precise palliative care
    • HORIZON-MISS-2026-02-CANCER-01: Virtual Human Twin (VHT) Models for Cancer Research
    • HORIZON-MISS-2026-02-CANCER-07: Improve the Quality of Life of older cancer patients
    • HORIZON-MISS-2026-02-CANCER-02: Microbiome for early cancer prediction before the onset of disease
    • HORIZON-MISS-2026-02-CANCER-06: Development of a research capacity building programme on cancer with and for Ukraine
    • HORIZON-MISS-2026-02-CANCER-03: Pragmatic clinical trials to optimise immunotherapeutic interventions for patients with refractory cancers
    • HORIZON-MISS-2026-02-CANCER-05: Boosting mental health of young cancer survivors through the European Cancer Patient Digital Centre (ECPDC)

    Miadreza Shafiekhah

    Head of Research and Innovation at Nowocert

    Dublin, Ireland

  • Project cooperation

    CortexView Imaging Intelligence™ – AI-Enhanced Acquisition and Diagnosis

    • HORIZON-MISS-2026-02-CANCER-04: Earlier and more precise palliative care
    • HORIZON-MISS-2026-02-CANCER-01: Virtual Human Twin (VHT) Models for Cancer Research
    • HORIZON-MISS-2026-02-CANCER-07: Improve the Quality of Life of older cancer patients
    • HORIZON-MISS-2026-02-CANCER-02: Microbiome for early cancer prediction before the onset of disease
    • HORIZON-MISS-2026-02-CANCER-06: Development of a research capacity building programme on cancer with and for Ukraine
    • HORIZON-MISS-2026-02-CANCER-03: Pragmatic clinical trials to optimise immunotherapeutic interventions for patients with refractory cancers
    • HORIZON-MISS-2026-02-CANCER-05: Boosting mental health of young cancer survivors through the European Cancer Patient Digital Centre (ECPDC)

    Miadreza Shafiekhah

    Head of Research and Innovation at Nowocert

    Dublin, Ireland